Acurx Pharmaceuticals Inc Sustainability Reports
Acurx Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing a new class of small molecule antibiotics for difficult-to-treat bacterial infections. Its drug candidates target the DNA polymerase IIIC enzyme to block DNA replication in Gram-positive bacteria.
Sector: Manufacturing
Country: United States
Exchange: Nasdaq
LEI: 5493006KI0IEUHE1UK56
FIGI: BBG01184DNK2
4 reports from 2021 to 2024
